Kun Lieh Yang
Direktor/Vorstandsmitglied bei FORMOSAN UNION CHEMICAL CORP.
Aktive Positionen von Kun Lieh Yang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FORMOSAN UNION CHEMICAL CORP. | Direktor/Vorstandsmitglied | 01.06.2002 | - |
UNITED BIOPHARMA INC | Direktor/Vorstandsmitglied | - | - |
Hong Jing Resources Co., Ltd.
Hong Jing Resources Co., Ltd. Financial ConglomeratesFinance Hong Jing Resources Co., Ltd. engages in the operation of waste treatment enterprises. Its business activities include waste removal, environmental testing services, waste cleaning, hardware wholesale, non-ferrous metal, and international trade industries. The company was founded on January 20, 2006 and is headquartered in Kaohsiung, Taiwan. | Vorsitzender | 04.07.2017 | - |
Formosa Biomedical Technology Corp.
Formosa Biomedical Technology Corp. Household/Personal CareConsumer Non-Durables Formosa Biomedical Technology Corp. engages in developing and manufacturing high-tech, quality, safe and healthy products by integrating its three major resources of Formosa Group in manufacturing, academic studies and clinical research & services. The company was founded on November 10, 2009 and is headquartered in Taipei, China. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | 06.03.2012 | - |
Karriereverlauf von Kun Lieh Yang
Statistik
International
Taiwan | 5 |
Operativ
Director/Board Member | 3 |
Chairman | 1 |
Chief Executive Officer | 1 |
Sektoral
Process Industries | 2 |
Health Technology | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
FORMOSAN UNION CHEMICAL CORP. | Process Industries |
Private Unternehmen | 3 |
---|---|
United BioPharma, Inc.
United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
Hong Jing Resources Co., Ltd.
Hong Jing Resources Co., Ltd. Financial ConglomeratesFinance Hong Jing Resources Co., Ltd. engages in the operation of waste treatment enterprises. Its business activities include waste removal, environmental testing services, waste cleaning, hardware wholesale, non-ferrous metal, and international trade industries. The company was founded on January 20, 2006 and is headquartered in Kaohsiung, Taiwan. | Finance |
Formosa Biomedical Technology Corp.
Formosa Biomedical Technology Corp. Household/Personal CareConsumer Non-Durables Formosa Biomedical Technology Corp. engages in developing and manufacturing high-tech, quality, safe and healthy products by integrating its three major resources of Formosa Group in manufacturing, academic studies and clinical research & services. The company was founded on November 10, 2009 and is headquartered in Taipei, China. | Consumer Non-Durables |
- Börse
- Insiders
- Kun Lieh Yang
- Erfahrung